IR
IDXX icon

Invictus RG’s Idexx Laboratories IDXX Stock Holding History

Invictus RG’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-1,537
Closed -$335K – 209
2018
Q2 		$335K Sell
1,537
-472
-23% -$97.3K 0.28% 96
2018
Q1 		$385K Buy
+2,009
New +$371K 0.26% 85
2017
Q3 		– Sell
-40
Closed -$6K – 594
2017
Q2 		$6K Sell
40
-3,798
-99% -$617K ﹤0.01% 585
2017
Q1 		$593K Buy
3,838
+1,020
+36% +$141K 0.4% 28
2016
Q4 		$330K Buy
2,818
+2,201
+357% +$251K 0.22% 180
2016
Q3 		$70K Buy
617
+129
+26% +$13.6K 0.05% 435
2016
Q2 		$45K Buy
488
+203
+71% +$17.4K 0.05% 363
2016
Q1 		$22K Buy
+285
New +$20.5K 0.03% 411

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Invictus RG's IDXX Position: Q3 2018 in Review

Invictus RG sold out of Idexx Laboratories (IDXX) in Q3 2018, closing a stake of 1,537 shares — an estimated $335K sold.

Invictus RG first reported a position in IDXX in Q1 2016 and held it in 8 quarters. The position peaked at $593K in Q1 2017. 698 funds tracked by Wall St. Rank hold IDXX as of Q3 2018.

  • Invictus RG reported no remaining Idexx Laboratories position as of Q3 2018 after selling out during the quarter.
  • Invictus RG sold 1,537 Idexx Laboratories shares in Q3 2018, an estimated $335K.
  • Invictus RG first reported a position in Idexx Laboratories in Q1 2016 and held it in 8 quarters.
  • Invictus RG's Idexx Laboratories position peaked at $593K in Q1 2017.
  • 698 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2018.

Based on Invictus RG's 13F filing for Q3 2018, filed 13 Nov 2018.